Information blocking has been a hot-button issue for years as it has impeded innovation and patient healthcare options for too long. The 21st Century Cures Act (Cures Act) sought to eliminate these problems but information blocking persisted. However, in February 2019 the Office of the National Coordinator for Health Information Technology (ONC) announced a proposed rule with consequences to non-compliance with the Cures Act that may finally force true interoperability. As a healthcare decision maker you have a real opportunity to build an innovation strategy around these changes. To learn how, join our webinar.
Tuesday, June 18
1:00-2:00 PM ET
True data interoperability enables innovation and better patient experience. In aggregate, both of these activities have the potential to accelerate the shift away from fee-for-service and towards fee-for-value healthcare. Dan Orenstein has spent much of his career providing legal counsel to healthcare organizations on regulatory and risk management issues as well as how to implement growth initiatives that comply with healthcare laws and regulations. That experience has made him an expert in applying policy to healthcare strategy. He has studied the proposed rule and in this webinar he will provide a summary of the existing legislation, implications of non-compliance with the proposed rule as well as insight into putting it into practice.
Attend this webinar and learn:
Dan Orenstein is the General Counsel and Secretary of the Board, with responsibility for all aspects of legal and regulatory affairs at Health Catalyst. Orenstein has nearly two decades of private practice and in-house legal and executive experience in healthcare and information technology. For the 10 years prior to joining Health Catalyst, Orenstein worked at athenahealth, Inc. (NASDAQ: ATHN), a publicly traded healthcare IT company and pioneer in results-oriented, cloud-enabled services, serving as General Counsel during his last 7 years with athenahealth. At athenahealth, Orenstein helped to steer the company through a period of rapid and sustained growth, including supporting the company’s 2007 IPO, standardizing and scaling the company’s revenue contracting processes, and advising on service design to ensure compliance with health regulations. Prior to joining athenahealth, Orenstein practiced in the areas of corporate, intellectual property, and healthcare law with law firms in Boston and Washington, D.C. He has written and presented on a number of topics involving healthcare law and technology, and has served in a leadership role with the American Health Lawyers Association. Orenstein received his bachelor’s degree from Columbia University and his law degree from the Georgetown University Law Center.